Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Aurora Biosciences (ABSC) -- Ignore unavailable to you. Want to Upgrade?

To: Andy Patton who wrote (153)	8/25/1998 3:39:00 AM
From: Richard Haugland	Read Replies (1) \| Respond to of 359

I was going to post my third "dismal performance of ABSC" again yesterday after the close but thought that that may be redundant. ABSC's revenues last FY were about $20,400,000 from all sources biz.yahoo.com so that the $9+ million from the agreement over 15 months represents a healthy chunk of revenues for ABSC. It certainly looked positive to me and I cannot imagine that it is that announcement that would make the stock sell off to a new all-time low of 4 1/2 yesterday. I hate to commit even more funds but it has to look like a buy at these prices, even if for only the short term. I don't know where the bottom is going to be but expect that it will correct to at least $6 again soon, as it did when it fell to its previous low of about 5 1/8. The link also shows short interest of only 64,000 shares, which is very low.